申请人:Apotex Inc.
公开号:US05677302A1
公开(公告)日:1997-10-14
Novel thiadiazole compounds are provided, which are effective as proton pumps inhibitors, useful in treating peptic ulcers by inhibition of the proton pump enzyme H.sup.+ /K.sup.+ -ATPase. The compounds are 3-substituted 1,2,4-thiadiazolo \x9b4,5-.alpha.!benzimidazole and 3-substituted imidazo\x9b1,2-d!-1,2,4-thiadiazoles corresponding to the general formula: ##STR1## where X and Z either represent an optionally substituted benzene ring fused to the diazole nucleus, or represent a variety of independent chemical groupings (hydrogen, lower alkyl, halo, etc.) and Y is an electronegative group.
提供了新型噻二唑化合物,作为质子泵抑制剂具有有效性,在治疗胃溃疡中通过抑制质子泵酶H.sup.+ /K.sup.+ -ATPase起作用。这些化合物是3-取代的1,2,4-噻二唑并噻唑并咪唑和3-取代的咪唑并\x9b1,2-d!-1,2,4-噻二唑,对应于以下一般公式:##STR1## 其中X和Z可以表示可选择取代的苯环与噻二唑核融合,或表示各种独立的化学基团(氢、较低的烷基、卤素等),Y是一个电负性基团。